Suk-Young Hwang
Comptroller/Controller/Auditor chez Celltrion Skincure Co., Ltd.
Profil
Suk-Young Hwang is currently working as an Auditor at Celltrion Skincure Co., Ltd.
since 2017.
Prior to this, Mr. Hwang worked as a Director & Auditor at Celltrion Healthcare Co., Ltd.
Postes actifs de Suk-Young Hwang
| Sociétés | Poste | Début |
|---|---|---|
Celltrion Skincure Co., Ltd.
 Celltrion Skincure Co., Ltd. Pharmaceuticals: MajorHealth Technology Celltrion GSC Co., Ltd. is a holding company, which manufactures pharmaceutical subsidiary materials. It also engages in research and development of pharmaceutical materials and product localization. The company was founded on June 14, 2000 and is headquartered in Incheon, South Korea. | Comptroller/Controller/Auditor | 29/03/2017 |
Anciens postes connus de Suk-Young Hwang
| Sociétés | Poste | Fin |
|---|---|---|
| CELLTRION HEALTHCARE CO., LTD. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Celltrion Skincure Co., Ltd.
Celltrion Skincure Co., Ltd. Pharmaceuticals: MajorHealth Technology Celltrion GSC Co., Ltd. is a holding company, which manufactures pharmaceutical subsidiary materials. It also engages in research and development of pharmaceutical materials and product localization. The company was founded on June 14, 2000 and is headquartered in Incheon, South Korea. | Health Technology |
Celltrion Healthcare Co., Ltd.
 Celltrion Healthcare Co., Ltd. Pharmaceuticals: MajorHealth Technology Celltrion Healthcare Co., Ltd. manufactures pharmaceutical products. Its products include infliximab, rituximab, and trastuzumab biosimilars. The company was founded on December 29, 1999 and is headquartered in Incheon, South Korea. | Health Technology |
